Year-over-year articles
HOFSETH BIOCARE ASA
18 crawlable comparisons of consecutive annual reports.
Full company analysis · Org.nr 994 464 663
Grew 97215% on revenue, weaker earnings
Comparing Årsregnskap 2025 with 2024 for HOFSETH BIOCARE ASA. Revenue 267.0k NOK → 259.86m NOK (+97215.2%). Net result -97.90m NOK → -127.58m NOK. Equity…
Grew 22% on revenue, fresh owner capital
Comparing Årsregnskap 2024 with 2023 for HOFSETH BIOCARE ASA. Revenue 218.4k NOK → 267.0k NOK (+22.3%). Net result -93.00m NOK → -97.90m NOK. Equity 74.61m…
Shrank 100% on revenue, stronger earnings, fresh owner capital
Comparing Årsregnskap 2023 with 2022 for HOFSETH BIOCARE ASA. Revenue 119.96m NOK → 218.4k NOK (-99.8%). Net result -119.37m NOK → -93.00m NOK. Equity…
Grew 36% on revenue
Comparing Årsregnskap 2022 with 2021 for HOFSETH BIOCARE ASA. Revenue 88.05m NOK → 119.96m NOK (+36.2%). Net result -122.24m NOK → -119.37m NOK. Equity…
Grew 28% on revenue, cash halved-plus
Comparing Årsregnskap 2021 with 2020 for HOFSETH BIOCARE ASA. Revenue 68.71m NOK → 88.05m NOK (+28.1%). Net result -105.28m NOK → -122.24m NOK. Equity…
Grew 17% on revenue, fresh owner capital
Comparing Årsregnskap 2020 with 2019 for HOFSETH BIOCARE ASA. Revenue 58.50m NOK → 68.71m NOK (+17.5%). Net result -89.21m NOK → -105.28m NOK. Equity…
Grew 17% on revenue
Comparing Årsregnskap 2019 with 2018 for HOFSETH BIOCARE ASA. Revenue 49.88m NOK → 58.50m NOK (+17.3%). Net result -84.77m NOK → -89.21m NOK. Equity 87.45m…
Shrank 47% on revenue, weaker earnings
Comparing Årsregnskap 2018 with 2017 for HOFSETH BIOCARE ASA. Revenue 94.54m NOK → 49.88m NOK (-47.2%). Net result -36.17m NOK → -84.77m NOK. Equity 37.68m…
Grew 379% on revenue, stronger earnings, fresh owner capital
Comparing Årsregnskap 2017 with 2016 for HOFSETH BIOCARE ASA. Revenue 19.75m NOK → 94.54m NOK (+378.6%). Net result -146.18m NOK → -36.17m NOK. Equity…
Shrank 64% on revenue, weaker earnings, cash halved-plus
Comparing Årsregnskap 2016 with 2015 for HOFSETH BIOCARE ASA. Revenue 54.78m NOK → 19.75m NOK (-63.9%). Net result -100.20m NOK → -146.18m NOK. Equity…
Grew 184% on revenue, weaker earnings
Comparing Årsregnskap 2015 with 2014 for HOFSETH BIOCARE ASA. Revenue 19.29m NOK → 54.78m NOK (+184.0%). Net result -66.92m NOK → -100.20m NOK. Equity…
Shrank 69% on revenue, weaker earnings, fresh owner capital
Comparing Årsregnskap 2014 with 2013 for HOFSETH BIOCARE ASA. Revenue 62.69m NOK → 19.29m NOK (-69.2%). Net result -52.13m NOK → -66.92m NOK. Equity 69.20m…
Grew 141% on revenue, stronger earnings, fresh owner capital
Comparing Årsregnskap 2013 with 2012 for HOFSETH BIOCARE ASA. Revenue 26.02m NOK → 62.69m NOK (+141.0%). Net result -73.86m NOK → -52.13m NOK. Equity 48.47m…
Grew 14215747% on revenue, weaker earnings, cash halved-plus
Comparing Årsregnskap 2012 with 2011 for HOFSETH BIOCARE ASA. Revenue 183 NOK → 26.02m NOK (+14215747.0%). Net result -19.03m NOK → -73.86m NOK. Equity…
Shrank 100% on revenue, weaker earnings, fresh owner capital
Comparing Årsregnskap 2011 with 2010 for HOFSETH BIOCARE ASA. Revenue 170.7k NOK → 183 NOK (-99.9%). Net result -9.39m NOK → -19.03m NOK. Equity 75.96m NOK…
Fresh owner capital
Comparing Årsregnskap 2010 with 2009 for HOFSETH BIOCARE ASA. Equity 24.4k NOK → 75.96m NOK.
Fresh owner capital
Comparing Årsregnskap 2009 with 2008 for HOFSETH BIOCARE ASA. Equity 229 NOK → 24.4k NOK.
First published accounts
First year in the published series for HOFSETH BIOCARE ASA (2008). No prior-year comparative in this dataset.